title: Extended pancreas donor program - the EXPAND study rationale and study protocol.
abstract: BACKGROUND
  Simultaneous pancreas kidney transplantation (SPK), pancreas transplantation alone (PTA) or pancreas transplantation after kidney (PAK) are the only curative treatment options for patients with type 1 (juvenile) diabetes mellitus with or without impaired renal function. Unfortunately, transplant waiting lists for this indication are increasing because the current organ acceptability criteria are restrictive; morbidity and mortality significantly increase with time on the waitlist. Currently, only pancreas organs from donors younger than 50 years of age and with a body mass index (BMI) less than 30 are allocated for transplantation in the Eurotransplant (ET) area. To address this issue we designed a study to increase the available donor pool for these patients.
  
  
  METHODS
  This study is a prospective, multicenter (20 German centers), single blinded, non-randomized, two armed trial comparing outcome after SPK, PTA or PAK between organs with the currently allowed donor criteria versus selected organs from donors with extended criteria. Extended donor criteria are defined as organs procured from donors with a BMI of 30 to 34 or a donor age between 50 and 60 years. Immunosuppression is generally standardized using induction therapy with Myfortic, tacrolimus and low dose steroids. In principle, all patients on the waitlist for primary SPK, PTA or PAK are eligible for the clinical trial when they consent to possibly receiving an extended donor criteria organ. Patients receiving an organ meeting the current standard criteria for pancreas allocation (control arm) are compared to those receiving extended criteria organ (study arm); patients are blinded for a follow-up period of one year. The combined primary endpoint is survival of the pancreas allograft and pancreas allograft function after three months, as an early relevant outcome parameter for pancreas transplantation.
  
  
  CONCLUSIONS
  The EXPAND Study has been initiated to investigate the hypothesis that locally allocated extended criteria organs can be transplanted with similar results compared to the currently allowed standard ET organ allocation. If our study shows a favorable comparison to standard organ allocation criteria, the morbidity and mortality for patients waiting for transplantation could be reduced in the future.
  
  
  BACKGROUND
  Trial registered at: NCT01384006.
authors.affiliation: Department of Surgery, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. stefan.farkas@ukr.de.
authors.forename: Andrea
authors.initials: A
authors.lastname: Proneth
authors.forename: Andreas A
authors.initials: AA
authors.lastname: Schnitzbauer
authors.forename: Florian
authors.initials: F
authors.lastname: Zeman
authors.forename: Johanna R
authors.initials: JR
authors.lastname: Foerster
authors.forename: Ines
authors.initials: I
authors.lastname: Holub
authors.forename: Helmut
authors.initials: H
authors.lastname: Arbogast
authors.forename: Wolf O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: Thomas
authors.initials: T
authors.lastname: Becker
authors.forename: Carsten
authors.initials: C
authors.lastname: Dietz
authors.forename: Markus
authors.initials: M
authors.lastname: Guba
authors.forename: Michael
authors.initials: M
authors.lastname: Heise
authors.forename: Sven
authors.initials: S
authors.lastname: Jonas
authors.forename: Stephan
authors.initials: S
authors.lastname: Kersting
authors.forename: Jürgen
authors.initials: J
authors.lastname: Klempnauer
authors.forename: Steffen
authors.initials: S
authors.lastname: Manekeller
authors.forename: Volker
authors.initials: V
authors.lastname: Müller
authors.forename: Silvio
authors.initials: S
authors.lastname: Nadalin
authors.forename: Björn
authors.initials: B
authors.lastname: Nashan
authors.forename: Andreas
authors.initials: A
authors.lastname: Pascher
authors.forename: Falk
authors.initials: F
authors.lastname: Rauchfuss
authors.forename: Michael A
authors.initials: MA
authors.lastname: Ströhlein
authors.forename: Peter
authors.initials: P
authors.lastname: Schemmer
authors.forename: Peter
authors.initials: P
authors.lastname: Schenker
authors.forename: Stefan
authors.initials: S
authors.lastname: Thorban
authors.forename: Thomas
authors.initials: T
authors.lastname: Vogel
authors.forename: Axel O
authors.initials: AO
authors.lastname: Rahmel
authors.forename: Richard
authors.initials: R
authors.lastname: Viebahn
authors.forename: Bernhard
authors.initials: B
authors.lastname: Banas
authors.forename: Edward K
authors.initials: EK
authors.lastname: Geissler
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Schlitt
authors.forename: Stefan A
authors.initials: SA
authors.lastname: Farkas